Literature DB >> 26383166

HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.

Yuichi Mitobe1, Jun-ichirou Yasunaga2, Rie Furuta3, Masao Matsuoka2.   

Abstract

Infection of T cells with human T-cell leukemia virus type-1 (HTLV-1) induces clonal proliferation and is closely associated with the onset of adult T-cell leukemia-lymphoma (ATL) and inflammatory diseases. Although Tax expression is frequently suppressed in HTLV-1-infected cells, the accessory gene, HTLV-1 bZIP factor (HBZ), is continuously expressed and has been implicated in HTLV-1 pathogenesis. Here, we report that transduction of mouse T cells with specific mutants of HBZ that distinguish between its RNA and protein activity results in differential effects on T-cell proliferation and survival. HBZ RNA increased cell number by attenuating apoptosis, whereas HBZ protein induced apoptosis. However, both HBZ RNA and protein promoted S-phase entry of T cells. We further identified that the first 50 bp of the HBZ coding sequence are required for RNA-mediated cell survival. Transcriptional profiling of T cells expressing wild-type HBZ, RNA, or protein revealed that HBZ RNA is associated with genes involved in cell cycle, proliferation, and survival, while HBZ protein is more closely related to immunological properties of T cells. Specifically, HBZ RNA enhances the promoter activity of survivin, an inhibitor of apoptosis, to upregulate its expression. Inhibition of survivin using YM155 resulted in impaired proliferation of several ATL cell lines as well as a T-cell line expressing HBZ RNA. The distinct functions of HBZ RNA and protein may have several implications for the development of strategies to control the proliferation and survival mechanisms associated with HTLV-1 infection and ATL. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26383166     DOI: 10.1158/0008-5472.CAN-15-0942

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  39 in total

1.  HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia.

Authors:  Jingyu Xiang; Daniel A Rauch; Devra D Huey; Amanda R Panfil; Xiaogang Cheng; Alison K Esser; Xinming Su; John C Harding; Yalin Xu; Gregory C Fox; Francesca Fontana; Takayuki Kobayashi; Junyi Su; Hemalatha Sundaramoorthi; Wing Hing Wong; Yizhen Jia; Thomas J Rosol; Deborah J Veis; Patrick L Green; Stefan Niewiesk; Lee Ratner; Katherine N Weilbaecher
Journal:  JCI Insight       Date:  2019-10-03

2.  Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs.

Authors:  Keith Durkin; Nicolas Rosewick; Maria Artesi; Vincent Hahaut; Philip Griebel; Natasa Arsic; Arsène Burny; Michel Georges; Anne Van den Broeke
Journal:  Retrovirology       Date:  2016-05-03       Impact factor: 4.602

3.  HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.

Authors:  A Kawatsuki; J-I Yasunaga; Y Mitobe; P L Green; M Matsuoka
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

4.  Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma.

Authors:  Kyohei Yamada; Hiroaki Miyoshi; Noriaki Yoshida; Joji Shimono; Kensaku Sato; Kazutaka Nakashima; Mai Takeuchi; Fumiko Arakawa; Naoko Asano; Eriko Yanagida; Masao Seto; Koichi Ohshima
Journal:  Mod Pathol       Date:  2020-09-24       Impact factor: 7.842

5.  Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.

Authors:  Jane Murphy; William W Hall; Lee Ratner; Noreen Sheehy
Journal:  Virology       Date:  2016-04-22       Impact factor: 3.616

6.  Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.

Authors:  Manraj Singh Narulla; Ahlam Alsairi; Lucie Charmier; Stephen Noonan; David Conroy; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

7.  Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery.

Authors:  Hélène Gazon; Pradeep Singh Chauhan; Florent Porquet; Gabriela Brunsting Hoffmann; Roberto Accolla; Luc Willems
Journal:  Blood Adv       Date:  2020-11-10

8.  Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Kazuya Shimura; Keiko Takemoto; Miho Watanabe; Masayuki Amano; Hirotomo Nakata; Benquan Liu; Xiaorui Zuo; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

Review 9.  HIV-1 Natural Antisense Transcription and Its Role in Viral Persistence.

Authors:  Rui Li; Rachel Sklutuis; Jennifer L Groebner; Fabio Romerio
Journal:  Viruses       Date:  2021-04-29       Impact factor: 5.048

Review 10.  From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis.

Authors:  Eléonore Pérès; Eugénie Bagdassarian; Sébastien This; Julien Villaudy; Dominique Rigal; Louis Gazzolo; Madeleine Duc Dodon
Journal:  Viruses       Date:  2015-12-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.